Pharma Topics
Trending

PharmaGlobal
GLP-1 weight-loss drugs lock patients into lifelong dependence instead of fixing the causes of obesity.
04-Nov-2026
GLP-1 drugs such as semaglutide produce substantial weight loss, but many patients regain weight when they stop taking them. Critics say this creates open-ended dependence while food environments and lifestyles stay unchanged. Supporters say obesity is a chronic disease like high blood pressure, and that long-term treatment is as legitimate as any other.
04-Nov-2026

PharmaGlobal
Intellectual property regimes severely impede the equitable global distribution of critical, life-saving medical innovations.
23-Jul-2026
Public Health Policy
23-Jul-2026
1 topics remaining
Recently Visited

PharmaGlobal
The global market dominance of Western pharmaceutical conglomerates inherently suppresses and delegitimizes indigenous medical systems.
23-Jul-2026
Medical Hegemony
23-Jul-2026